Founder BRCA1/2 mutations in the Europe: implications for hereditary breast-ovarian cancer prevention and control

BRCA1gene mutations may explain more than 80% of excess number of ovarian cancer cases after breast cancer – a population based study from the Western Sweden Health Care region

(2010) Zakaria Einbeigi et al.   ACTA ONCOLOGICA

Screening for genomic rearrangements in BRCA1 and BRCA2 genes in Czech high-risk breast/ovarian cancer patients: high proportion of population specific alterations in BRCA1 gene

(2010) Ivana Ticha et al.   BREAST CANCER RESEARCH AND TREATMENT

Interlaboratory Diagnostic Validation of Conformation-Sensitive Capillary Electrophoresis for Mutation Scanning

(2010) C. J. Mattocks et al.   CLINICAL CHEMISTRY

The contribution of founder mutations in BRCA1 to breast and ovarian cancer in Lithuania

(2010) P Elsakov et al.   CLINICAL GENETICS

High-resolution DNA melting analysis in clinical research and diagnostics

(2010) Jesse L Montgomery et al.   EXPERT REVIEW OF MOLECULAR DIAGNOSTICS

Hereditary breast and ovarian cancer due to mutations in BRCA1 and BRCA2

(2010) Nancie Petrucelli et al.   GENETICS IN MEDICINE

A role of BRCA1 and BRCA2germline mutations in breast cancer susceptibility within Sardinian population

(2009) Grazia Palomba et al.   BMC CANCER

Two founder BRCA2 mutations predispose to breast cancer in young women

(2009) Mar Infante et al.   BREAST CANCER RESEARCH AND TREATMENT

Is early onset breast cancer with no family history a good criterion for testingBRCA1andBRCA2genes? A small population-based study

(2009)   CLINICAL GENETICS

The contribution of founder mutations to early-onset breast cancer in French-Canadian women

(2009) P Ghadirian et al.   CLINICAL GENETICS

BRCA15272-1G>A andBRCA25374delTATG are founder mutations of high relevance for genetic counselling in breast/ovarian cancer families of Spanish origin

(2009) M Infante et al.   CLINICAL GENETICS

Heterogeneous prevalence of recurrent BRCA1 and BRCA2 mutations in Spain according to the geographical area: implications for genetic testing

(2009) Orland Diez et al.   Familial Cancer

A high frequent BRCA1 founder mutation identified in the Greenlandic population

(2009) Theresa Larriba Harboe et al.   Familial Cancer

Pathologic Complete Response Rates in Young Women With BRCA1-Positive Breast Cancers After Neoadjuvant Chemotherapy

(2009) Tomasz Byrski et al.   JOURNAL OF CLINICAL ONCOLOGY

Survival Analysis of Cancer Risk Reduction Strategies forBRCA1/2Mutation Carriers

(2009) Allison W. Kurian et al.   JOURNAL OF CLINICAL ONCOLOGY

Meta-analysis of Risk Reduction Estimates Associated With Risk-Reducing Salpingo-oophorectomy in BRCA1 or BRCA2 Mutation Carriers

(2009) T. R. Rebbeck et al.   JNCI-Journal of the National Cancer Institute

The Contribution of BRCA1 and BRCA2 to Ovarian Cancer

(2009) Susan J. Ramus et al.   Molecular Oncology

Inhibition of Poly(ADP-Ribose) Polymerase in Tumors fromBRCAMutation Carriers

(2009) Peter C. Fong et al.   NEW ENGLAND JOURNAL OF MEDICINE

MRI and Mammography Surveillance of Women at Increased Risk for Breast Cancer

(2008) Elon J. Granader et al.   ACADEMIC RADIOLOGY

BRCA1 and BRCA2 mutations in Danish families with hereditary breast and/or ovarian cancer

(2008) Mads Thomassen et al.   ACTA ONCOLOGICA

Reconstructing the Genealogy of a BRCA1 Founder Mutation by Phylogenetic Analysis

(2008) F. Marroni et al.   ANNALS OF HUMAN GENETICS

Spectrum and characterisation of BRCA1 and BRCA2deleterious mutations in high-risk Czech patients with breast and/or ovarian cancer

(2008) Eva Machackova et al.   BMC CANCER

Analysis of large deletions in BRCA1, BRCA2 and PALB2 genes in Finnish breast and ovarian cancer families

(2008) Katri Pylkäs et al.   BMC CANCER

Five recurrent BRCA1/2 mutations are responsible for cancer predisposition in the majority of Slovenian breast cancer families

(2008) Mateja Krajc et al.   BMC Medical Genetics

Is BRCA1-5083del19, identified in breast cancer patients of Sicilian origin, a Calabrian founder mutation?

(2008) Antonio Russo et al.   BREAST CANCER RESEARCH AND TREATMENT

A common Greenlandic Inuit BRCA1 RING domain founder mutation

(2008) Thomas v. O. Hansen et al.   BREAST CANCER RESEARCH AND TREATMENT

Novel and common BRCA1 mutations in familial breast/ovarian cancer patients from Lithuania

(2008) Ramūnas Janavičius et al.   BREAST CANCER RESEARCH AND TREATMENT

Founder mutations account for the majority of BRCA1-attributable hereditary breast/ovarian cancer cases in a population from Tuscany, Central Italy

(2008) Laura Papi et al.   BREAST CANCER RESEARCH AND TREATMENT

Large BRCA1 and BRCA2 genomic rearrangements in Danish high risk breast-ovarian cancer families

(2008) Thomas v. O. Hansen et al.   BREAST CANCER RESEARCH AND TREATMENT

The c.156_157insAlu BRCA2 rearrangement accounts for more than one-fourth of deleterious BRCA mutations in northern/central Portugal

(2008) Ana Peixoto et al.   BREAST CANCER RESEARCH AND TREATMENT

Founder effect of the BRCA1 5382insC mutation in Brazilian patients with hereditary breast ovary cancer syndrome

(2008) E.C.B. da Costa et al.   CANCER GENETICS AND CYTOGENETICS

BRCA1 and BRCA2 Mutation Prevalence and Clinical Characteristics of a Population-Based Series of Ovarian Cancer Cases from Denmark

(2008) M. Soegaard et al.   CLINICAL CANCER RESEARCH

Hereditary breast cancer: from bench to bedside

(2008) Jacques De Grève et al.   CURRENT OPINION IN ONCOLOGY

Genomic screening identifies novel linkages and provides further evidence for a role of MYH9 in nonsyndromic cleft lip and palate

(2008) Brett T Chiquet et al.   EUROPEAN JOURNAL OF HUMAN GENETICS

The 4154delA mutation carriers in the BRCA1 gene share a common ancestry

(2008) Silvija Ozolina et al.   Familial Cancer

MLPA screening in theBRCA1gene from 1,506 German hereditary breast cancer cases: novel deletions, frequent involvement of exon 17, and occurrence in single early-onset cases

(2008) Stefanie Engert et al.   HUMAN MUTATION

Risk-Reducing Salpingo-Oophorectomy for the Prevention of BRCA1- and BRCA2-Associated Breast and Gynecologic Cancer: A Multicenter, Prospective Study

(2008) Noah D. Kauff et al.   JOURNAL OF CLINICAL ONCOLOGY

Risk reducing mastectomy: outcomes in 10 European centres

(2008) D G R Evans et al.   JOURNAL OF MEDICAL GENETICS

Keeping Up With the Next Generation

(2008) John R. ten Bosch et al.   JOURNAL OF MOLECULAR DIAGNOSTICS

BRCA1p.Val1688del Is a Deleterious Mutation That Recurs in Breast and Ovarian Cancer Families From Northeast Italy

(2007) Sandro Malacrida et al.   JOURNAL OF CLINICAL ONCOLOGY